Potential Anti-inflammatory Activity of Brown Propolis Against Brain Ischemia Damage in Mice

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 192

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CJNS-9-2_001

تاریخ نمایه سازی: 9 اردیبهشت 1402

Abstract:

Background: Inflammation plays a major part in brain ischemia. Propolis is a polyphenol-rich hive product with a set of pharmaceutical properties. Objectives: This research aims to investigate the impact of water extracts of brown propolis (WEPs) on stroke outcomes and inflammatory responses in a rat model of permanent middle cerebral artery occlusion (MCAO). Materials & Methods: This experimental study was conducted in Rafsanjan, Iran, in ۲۰۱۷. WEPs were experimentally prepared from two regions in Iran. Gas chromatography–mass spectrometry and Folin–Ciocalteu assays were used to determine chemical portrayal and the total polyphenol content, respectively. A total of ۶۶ male adult mice were divided randomly into the surgical sham, control (vehicle-treated), and four WEPs-treated animal groups. WEPs-treated groups received doses of ۱۰۰ and ۲۰۰ (mg/kg, IP) four times, and their behavioral tests, brain edema, infarct volume, and tumor necrosis factor-alpha (TNF-α) level were evaluated. Results: The samples were not significantly different in terms of the concentration of the total polyphenol content. Compared to the control, WEPs led to a substantial decrease in the TNF-α level (P<۰.۰۵) as well as a subsequent reduction in the brain edema and infarct volume (P<۰.۰۰۱) in all treatment groups. Furthermore, there was a significant improvement in neurological deficits and sensory-motor impairments level (P<۰.۰۵). Conclusion: According to the study findings, WEPs reduce brain ischemia damage, perhaps by exerting a neuroprotective effect on stroke-induced neuroinflammatory responses

Authors

Mohammad Allahtavakoli

Physiology-Pharmacology Research Center, Research Institute of Basic Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Zahra Kamiab

Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Mohammad Yassin Zamanian

Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

Małgorzata Kujawska

Department of Toxicology, School of Pharmacy, Poznan University of Medical Sciences, Dojazd, Poland

Mohammad Taher Boroushaki

Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Reza Rahmani

Departments of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Mohammadreza Gholamrezapour

Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Fatemeh Pakvojoud

Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

Gholamreza Bazmandegan

Physiology-Pharmacology Research Center, Research Institute of Basic Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran